Previous close | 368.93 |
Open | 370.37 |
Bid | 376.48 x 100 |
Ask | 377.12 x 100 |
Day's range | 368.68 - 379.77 |
52-week range | 254.85 - 403.76 |
Volume | |
Avg. volume | 1,565,743 |
Market cap | 133.753B |
Beta (5Y monthly) | 1.38 |
PE ratio (TTM) | 68.06 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
SUNNYVALE, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2024. Q1 Highlights Worldwide da Vinci procedures grew approximately 16% compared with the first quarter of 2023.The Company placed 313 da Vinci surgical systems, compared with 312 in the first quarter of 2023.The Company grew its da Vinci
Da Vinci 5 builds on decades of Intuitive technology and millions of robotic procedures Intuitive da Vinci 5 insufflator A view of Intuitive's da Vinci 5 insufflator screen Intuitive da Vinci 5 Tower A view of Intuitive's da Vinci 5 tower Intuitive da Vinci 5 full system Intuitive's da Vinci 5 Intuitive da Vinci 5 surgeon console A view of Intuitive's da Vinci 5 surgeon console SUNNYVALE, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally
SUNNYVALE, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2023. Q4 Highlights Worldwide da Vinci procedures grew approximately 21% compared with the fourth quarter of 2022.The Company placed 415 da Vinci surgical systems, compared with 369 in the fourth quarter of 2022.The Company grew its da V